Literature DB >> 15530118

General inverse solid-phase synthesis method for C-terminally modified peptide mimetics.

Ramakrishna Sasubilli1, William G Gutheil.   

Abstract

Peptide mimetics are of considerable interest as bioactive agents and drugs. C-terminally modified peptide mimetics are of particular interest given the synthetic versatility of the carboxyl group and its derivatives. A general approach to C-terminally modified peptide mimetics, based on a urethane attachment strategy and amino acid t-butyl ester-based N-to-C peptide synthesis, is described. This approach is compatible with the reaction conditions generally employed for solution-phase peptide mimetic synthesis. To develop and demonstrate this approach, it was employed for the solid-phase synthesis of peptide trifluoromethyl ketones, peptide boronic acids, and peptide hydroxamic acids. The development of a versatile general approach to C-terminally modified peptides using readily available starting materials provides a basis for the combinatorial and parallel solid-phase synthesis of these peptide mimetic classes for bioactive agent screening and also provides a basis for the further development of solid-phase C-terminal functional group elaboration strategies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530118     DOI: 10.1021/cc049912d

Source DB:  PubMed          Journal:  J Comb Chem        ISSN: 1520-4766


  4 in total

1.  Facile analysis and sequencing of linear and branched peptide boronic acids by MALDI mass spectrometry.

Authors:  Jason B Crumpton; Wenyu Zhang; Webster L Santos
Journal:  Anal Chem       Date:  2011-03-30       Impact factor: 6.986

Review 2.  Recent advances in the synthesis of C-terminally modified peptides.

Authors:  Christine A Arbour; Lawrence G Mendoza; Jennifer L Stockdill
Journal:  Org Biomol Chem       Date:  2020-09-30       Impact factor: 3.890

3.  A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists.

Authors:  Takashi Yamamoto; Padma Nair; Josef Vagner; Tally Largent-Milnes; Peg Davis; Shou-Wu Ma; Edita Navratilova; Sharif Moye; Suneeta Tumati; Josephine Lai; Henry I Yamamura; Todd W Vanderah; Frank Porreca; Victor J Hruby
Journal:  J Med Chem       Date:  2008-02-12       Impact factor: 7.446

4.  Solution-phase synthesis of 2-cyano and 2-amido aziridinyl peptides.

Authors:  Stefania Fioravanti; Davide Massari; Alberto Morreale; Lucio Pellacani; Paolo A Tardella
Journal:  Tetrahedron       Date:  2008-01-31       Impact factor: 2.457

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.